Notable healthcare headlines for the week: CVS, Eli Lilly and Novartis in focus [Seeking Alpha]
Flu season is here. How much is the vaccine without insurance? [USA TODAY]
These sick kids can't be home for the holidays. This influencer is trying to help. [USA TODAY]
CVS Health (NYSE:CVS) had its price target raised by analysts at TD Cowen from $100.00 to $105.00. They now have a "buy" rating on the stock.
CVS Health (NYSE:CVS) was given a new $87.00 price target on by analysts at Sanford C. Bernstein.